The Future of Contract Research Outsourcing - Market Forecasts to 2015, Geographical Landscape and Competitive Benchmarking - GBI Research Reports

The Future of Contract Research Outsourcing - Market Forecasts to 2015, Geographical Landscape and Competitive Benchmarking

The Future of Contract Research Outsourcing - Market Forecasts to 2015, Geographical Landscape and Competitive Benchmarking - GBI Research Reports
The Future of Contract Research Outsourcing - Market Forecasts to 2015, Geographical Landscape and Competitive Benchmarking
Published Dec 01, 2009
69 pages — Published Dec 01, 2009
Price US$ 3,500.00  |  Buy this Report Now

About This Report

  
Abstract:

SummaryGBI Research, the leading business intelligence provider, has released its latest research, 'The Future of Contract Research Outsourcing - Market Forecasts to 2015, Geographical Landscape and Competitive Benchmarking'. The research provides key data, information and analysis of the global contract research outsourcing market. The report provides market overview, competitive landscape and market trends information on the contract research outsourcing market. This report provides comprehensive information on the different service models present in the industry, key trends affecting contract research organizations and key analytical content on the market dynamics. The report also reviews the competitive landscape in terms of mergers and acquisitions, strategic partnerships and service agreements.This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.ScopeThe scope of this report includes:- Overview of contract research outsourcing and key reasons why pharmaceutical and biotechnology companies outsource to contract research organizations- Comprehensive analysis of the fully-integrated and functional service models of contract research outsourcing- Market size (2006-2015) and company share (2008) data for global contract research outsourcing market- Qualitative analysis of market drivers, restraints and trends - Geographic landscape covering the emerging regions such as Central and Eastern Europe, Latin America, India and China for contract research outsourcing- Competitive landscape covering key players Quintiles, Covance, PPD, Charles River Laboratories and PARAXEL International- M&A landscape and opportunity analysis of the emerging markets- Regulatory landscape of the US and key European countries in the contract research outsourcing market Reasons to buyThe report will enhance your decision making capability. It will enable you to:- Develop key strategies to reduce expenditure on R&D by outsourcing to the contract research organizations- Develop a clear knowledge and understanding of how companies use contract research outsourcing to improve drug development productivity - Make informed decisions related to contract research outsourcing by building a thorough understanding of the benefits and drawbacks of contract research outsourcing- Identify leading contract research outsourcing destinations and the best practices for entering into contract research outsourcing agreements in different countries - Identify key players best positioned to take advantage of the emerging market opportunities- Make informed decisions related to the M&A activities in the contract research outsourcing market - Overcome the regulatory hurdles in the contract research outsourcing market- Make more informed business decisions from the insightful and in-depth analysis of the global contract research outsourcing market and the factors shaping it

  
Source:
Document ID
GBIHC004MR
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
1 Table of Contents45
1.1 List of Tables71
1.2 List of Figures72
2 Contract Research Outsourcing Introduction92
2.1 GBI Research Report Guidance101
3 Contract Research Outsourcing Overview118
3.1 Global Contract Research Outsourcing111
3.1.1 The Clinical Research Process121
3.1.1.1 Drug Discovery Phase121
3.1.1.2 Pre-Clinical Phase131
3.1.1.3 Phase I 131
3.1.1.4 Phase III131
3.1.1.5 Review and Approval from the Regulatory Agencies131
3.1.1.6 Post-Marketing Studies131
3.2 Outsourcing of Clinical Research and Trial Processes131
3.2.1 Clinical Research Outsourcing is Seen as a Solution to Problems Such as Rising Costs or Low Productivity 141
3.2.2 Strategic Outsourcing Delivers Greater Value by Understanding the Core Competencies of the Vendor and Outsourcing Companies141
3.3 Key Reasons for Outsourcing to Contract Research Organizations141
3.3.1 Desire to Reduce Costs is a Prime Reason for Contract Research Outsourcing151
3.3.2 Contract Research Organizations are Engaged in Reducing Time to Market in Order to Achieve a Competitive Edge151
3.3.3 Outsourcing Critical but Resource and Time Intensive Functions such as Data Management Allows Biopharmaceutical Companies to Focus on Core Competencies161
3.3.4 Evolving Risk Sharing Agreements Attract Biopharmaceutical Companies to Increase Contract Research Outsourcing161
3.3.5 Contract Research Organizations are Helping to Improve Clinical Research Quality Through Better Regulatory Understanding and Keeping Pace with Technological Advances171
3.3.6 Small and Medium Biopharmaceutical Companies can Leverage on the Resources of Contract Research Organizations171
3.3.7 Biopharmaceutical Companies Benefit from New Technologies that Contract Research Organization Have Access to172
4 Contract Research Outsourcing Service Models198
4.1 Contract Research Outsourcing Service Model191
4.1.1 Fully Integrated Service Model191
Functional Service Model201
4.2 Criteria for Selecting a Contract Research Organization211
Early Stage Drug Development Outsourcing221
4.3.1 Strategic or Tactical Advantages of Outsourcing221
4.3.2 Case Study221
4.3.2.1 Long Term Partnerships with Drug Discovery Service Provider221
4.4 Clinical Stage Drug Development Outsourcing231
4.4.1 Strategic or Tactical Advantages of Outsourcing231
4.4.2 Case Studies231
4.4.2.1 A Strategic Move by a Large Pharmaceutical Company231
4.4.2.2 End-to-End Clinical Data Management Solutions241
Late Stage Development Outsourcing251
4.5.1 Strategic or Tactical Advantages of Outsourcing251
4.5.1.1 Innovative Techniques by a Contract Research Organization to Finish the Targets in Specific Timeframes252
5 Contract Research Outsourcing Market Characterization2712
The Contract Research Outsourcing Market will Continue to Grow, Driven by the Demand by the Biopharmaceutical Industry271
5.2 Key Market Drivers281
5.2.1 Increasing R&D Expenditure and Decreasing Productivity in the Biopharmaceutical Industry - Promoting R&D Outsourcing283
5.2.2 Stringent Regulations and Complex Clinical Trials Forcing Biopharmaceutical Companies to Leverage on the Contract Research Organizations311
5.2.3 Restriction on Pricing and Reimbursement of Drugs Need for Managing Costs from Earliest Stages of Development311
5.2.4 The Increasing Number of Clinical Trials321
5.3 Key Market Restraints/ Challenges331
5.3.1 Quality Concerns331
5.3.2 Economic Recession341
5.4 Contract Research Outsourcing Market Trends341
5.4.1 The Number of Services Focusing on the Late Stage Clinical Development is Increasing351
5.4.2 The Clinical Research and Trials are Becoming more Globalized361
5.4.3 Pharmaceutical Companies are Moving to Strategic Partnerships with Contract Research Organizations371
5.4.4 Emerging Tools to Enhance Drug Discovery Process Will be Key Drivers in the Future 371
Contract Research Outsourcing Unmet Needs381
5.5.1 High Technology Needs and Integration381
5.5.2 Lack of Therapeutic Expertise381
5.5.3 Contract Research Organizations are Short of Experienced Research Professionals to Conduct the Clinical Trial Studies381
6 Contract Research Outsourcing Geographical Landscape395
6.1 Emerging Regions in the Global Contract Research Outsourcing Market401
6.1.1 Latin America401
6.1.1.1 Potential Advantages of the Latin American Contract Research Outsourcing Market401
6.1.2 Central and Eastern Europe (CEE)401
6.1.2.1 Potential Advantages of Central and East European Contract Research Outsourcing Market411
6.1.3 India411
6.1.3.1 Potential Advantages of the Indian Contract Research Outsourcing Market421
6.1.4 China421
6.1.4.1 Potential Advantages of the Chinese Contract Research Outsourcing Market431
7 Contract Research Outsourcing Regulatory Issues444
7.1 Contract Research Organizations are Subject to the Same Regulations as Biopharmaceutical Companies441
7.1.1 Regulation in the Drug Discovery Stage451
7.1.2 Regulation in the Preclinical Stage451
7.1.2.1 The Principles of Good Laboratory Practice451
7.1.3 Regulation in the Clinical Trials Stage451
7.1.3.1 The Principles of Good Clinical Practice 461
7.2 Regulations Governing Outsourcing to Other Regions461
7.2.1.1 FDA Requirements for Outsourcing471
7.2.1.2 European Union Requirements for Outsourcing471
7.2.1.3 Requirements in Emerging Countries471
8 Contract Research Outsourcing Competitive Landscape4811
8.1 Overview481
8.2 Market Share Analysis491
8.3 Competitive Profiling501
8.4 Quintiles Transnational Corp.511
8.4.1 Snapshot511
8.4.2 Business Description511
8.4.3 Recent M&A Deals and Strategic Alliances511
8.4.3.1 Strategic Alliance Agreement with the University of Pretoria511
8.4.3.2 Quintiles to Open Phase I Unit in India521
8.4.3.3 Quintiles Acquires Targeted Molecular Diagnostics521
8.4.3.4 QPS and Quintiles Collaborates for Cardiac Safety Service521
8.4.3.6 Quintiles to Provide Central Lab Services in Japan521
8.5 Covance Inc.531
8.5.1 Business Description531
8.5.2 Recent M&A Deals and Alliances531
8.5.2.1 Covance Agreed to Provide Genomic Analysis Services to Merck &Co., Inc.531
8.5.2.2 Covance Enters into a Multi-Year Marketing Agreement with Phase Forward531
8.5.2.3 Covance Acquired Swiss-Based Early Clinical Development Site541
8.5.2.4 Covance Purchased Equity Stake in Caprion Proteomics541
8.5.2.5 Covance and Eli Lilly Entered into a Strategic R&D Collaboration541
8.5.2.6 Covance and WuXi PharmaTech to Form a Joint Venture to Provide World-Class Preclinical Services in China541
8.6 Pharmaceutical Product Development (PPD) Inc.541
Business Description541
8.6.2 Recent M&A Deals and Alliances551
8.6.2.1 PPD Acquired AbCRO551
8.6.2.2 PPD Acquired Magen BioSciences551
8.6.2.3 PPD Expands Post-Approval Drug Safety Capabilities through Strategic Alliance with WHISCON551
8.6.2.4 PPD Enters Into Strategic Collaboration with Merck551
8.6.2.5 PPD Acquired InnoPharm551
8.7 Charles River Laboratories International, Inc.561
8.7.1 Business Description561
8.7.2 Recent M&A Deals and Alliances571
8.7.2.1 Charles River Acquired Cerebricon LTD571
8.7.2.2 Charles River Acquired Systems Pathology Company571
8.7.2.4 Charles River Acquired Molecular Imaging Research (MIR ) Preclinical Services571
8.8 PAREXEL International571
8.8.1 Business Description581
8.8.2 Recent M&A Deals and Alliances581
8.8.2.1 Perceptive Informatics Enhances Musculoskeletal Medical Imaging Capabilities through Alliance with Optasia581
8.8.2.2 Perceptive Informatics Enhances CNS and Oncology Medical Image Processing and Analysis Capabilities through Alliance with Biospective581
8.8.2.3 PAREXEL Establishes Alliance with SITS581
9 Contract Research Outsourcing Deals Analysis596
9.1 Mergers and Acquisitions591
9.1.1 Quintiles Acquires Targeted Molecular Diagnostics601
9.1.2 Quintiles Acquires Bio-Trials601
9.1.3 PPD Acquired Magen BioSciences601
9.1.5 ICON Acquires Prevalere Life Sciences Inc.601
9.1.6 ICON Acquires DOCS International611
9.1.7 MDS Inc Acquires Molecular Devices Corporation611
9.1.8 Kendle Acquires International Clinical Research611
9.1.9 PRA International Acquires Pharma Bio-Research611
9.2 Strategic Alliances, Service Agreements and Other Deals611
9.3 Deals by Year621
Deals by Therapeutic Area632
10 Contract Research Outsourcing Appendix655
10.1 Market Definitions651
10.2 Abbreviations651
10.3 Sources661
10.4 Methodology663
10.4.1 Coverage671
10.4.2 Secondary Research671
10.4.3 Primary Research681
10.4.4 Expert Panel Validation681
10.5 Contact Us681
10.6 Disclaimer682

Table Of Contents

GBI Research Reports—GBI Research covers worldwide markets and issues, supplies actionable data and forecasts and is driven by industry leaders' insights. GBI Research provides a broad spectrum of reports across the healthcare and energy industries and its online offering is easy to navigate - a comprehensive resource for business information needs.

About the Author


Cite this Report

  
MLA:
GBI Research Reports. "The Future of Contract Research Outsourcing - Market Forecasts to 2015, Geographical Landscape and Competitive Benchmarking" Dec 01, 2009. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GBI-Research-Reports/The-Future-of-Contract-Research-Outsourcing-Market-Forecasts-to-2015-Geographical-Landscape-and-Competitive-Benchmarking-2115-3>
  
APA:
GBI Research Reports. (2009). The Future of Contract Research Outsourcing - Market Forecasts to 2015, Geographical Landscape and Competitive Benchmarking Dec 01, 2009. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GBI-Research-Reports/The-Future-of-Contract-Research-Outsourcing-Market-Forecasts-to-2015-Geographical-Landscape-and-Competitive-Benchmarking-2115-3>
  
US$ 3,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.